Pancreatic hyperamylasemia during acute gastroenteritis: incidence and clinical relevanceG Tositti
Department of Infectious Diseases San Bortolo Hospital, Vial Rodolfi, 36100 Vicenza, Italy
BMC Infect Dis 1:18. 2001
..Many case reports of acute pancreatitis have been reported but, up to now, pancreatic abnormalities during acute gastroenteritis have not been studied prospectively...
Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis CPaolo Fabris
Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Viale Rodolfi 37, Vicenza, Italy
J Hepatol 41:644-51. 2004
..To evaluate: (1) the relationship between steatosis and either host or viral factors; (2) the correlation between steatosis and fibrosis in patients with CHC...
- Therapy of chronic hepatitis C virus infection in HIV co-infected people
P Fabris
Dept of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Viale Rodolfi, 36100 Vicenza, Italy
Curr Pharm Des 10:2111-22. 2004
..Liver transplantation is being evaluated in many centers. To date the experiences are very limited but encouraging in term of survival rate...
- Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C
Paolo Fabris
Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Viale Rodolfi, Vicenza 36100, Italy
J Clin Virol 29:160-6. 2004
..the frequency and the impact of occult HBV infection in patients with chronic hepatitis C infection is still a matter of some controversy...
- Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy
P Fabris
Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
Aliment Pharmacol Ther 18:549-58. 2003
..We suggest that islet cell autoantibodies and glutamic acid decarboxylase autoantibodies should be investigated before and during interferon treatment in order to identify subjects at high risk of developing type 1 diabetes mellitus...
- Impact of liver steatosis on virological response in [corrected] Italian patients with chronic hepatitis C treated with peg-interferon alpha-2b plus ribavarin
P Fabris
Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
Aliment Pharmacol Ther 21:1173-8. 2005
..Whether liver steatosis affects sustained virological response in patients with chronic hepatitis C is still under discussion...
- Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virus
Paolo Fabris
Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
J Med Virol 69:339-43. 2003
..Typical signs and symptoms of cryoglobulinemia do not correlate with the detection of circulating cryoglobulins in HIV and HCV patients...
- Assessing patients' understanding of hepatitis C virus infection and its impact on their lifestyle
P Fabris
Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
Aliment Pharmacol Ther 23:1161-70. 2006
..To assess how much patients with hepatitis C virus infection know about their condition and what impact it has on their lifestyle...
Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general populationPaolo Fabris
Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
J Clin Gastroenterol 42:527-32. 2008
....
- Serum pepsinogen and gastrin levels in HIV-positive patients: relationship with CD4+ cell count and Helicobacter pylori infection
P Fabris
Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
Aliment Pharmacol Ther 16:807-11. 2002
..The relationship between serum parameters of gastric function and Helicobacter pylori infection in human immunodeficiency virus (HIV)-positive patients is almost unknown...
- Impact of occult HBV infection in HIV/HCV co-infected patients: HBV-DNA detection in liver specimens and in serum samples
Paolo Fabris
Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
Curr HIV Res 6:173-9. 2008
..Occult B infection is relatively frequent in HIV/HCV co-infected patients, and is underestimated by common HBV-DNA serological assays. However, it doesn't seem to exert a relevant impact...
- Interferon alfa-2b alone or in combination with ketoprofen as treatment for interferon-naive chronic hepatitis C patients
P Fabris
Department of Infectious Diseases, S Bortolo Hospital, Vicenza, Italy
Aliment Pharmacol Ther 13:1329-34. 1999
..Non-steroidal anti-inflammatory drugs may amplify the anti-viral effect of alpha-interferon in vitro but in vivo data are still controversial...
- Chlamydia pneumoniae infection in HIV-positive patients: prevalence and relationship with lipid profile
G Tositti
Department of Infectious Diseases and Tropical Medicine, San Bortolo Hospital, Vincenza, Italy
HIV Med 6:27-32. 2005
..Furthermore, C. pneumoniae appears to be associated with hyperlipidaemia and might therefore represent a further risk factor for cardiovascolar disease in HIV-positive patients...
- Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection
P Fabris
Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
Curr Pharm Des 14:1661-5. 2008
..Identifying, in detail therefore, those factors that are responsible for viral control remains an important research goal not only to aid clinical management but also to develop effective treatment and vaccination strategies...
- Impact of interferon at induction chemotherapy and maintenance treatment for multiple myeloma. Preliminary results of a multicenter study by the Italian non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG)
G Capnist
San Bortolo Hospital, Vicenza, Italy
Acta Oncol 33:527-9. 1994
..Up to now, with a median follow-up of 9 months from the evaluation of response, no difference has been recorded between the maintenance and no maintenance groups on relapse rate, neither in good- nor in poor-prognosis patients...
Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infectionF de Lalla
Department of Infectious Diseases, San Bortolo Hospital, Vicenza, Italy
Antimicrob Agents Chemother 45:1094-8. 2001
..Further clinical studies aimed at precisely defining the role of this approach to this serious complication of diabetes mellitus appear to be justified...
- Clinical features of bacterial meningitis in Italy: a multicenter prospective observational study
L Lazzarini
Department of Infectious Diseases and Tropical Medicine, S Bortolo Hospital, Vicenza, Italy
J Chemother 20:478-87. 2008
..Mortality seemed to be lower in comparison with the literature...
- Successfull response to alpha 2b interferon plus ribavirin associated with venesectomies in a patient with chronic hepatitis C and genetic hemochromatosis
Paolo Fabris
J Gastroenterol Hepatol 18:116-7. 2003
- Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data
Gioacchino Leandro
IRCSS de Bellis, Castellana Grotte, Italy
Gastroenterology 130:1636-42. 2006
..Hepatic inflammation may mediate fibrogenesis in patients with liver steatosis. Control of metabolic factors (such as overweight, via lifestyle adjustments) appears important in the management of CHC...
- Onset of type 1 diabetes mellitus during peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C
Raffaele Cozzolongo
Divisione di Gastroenterologia, Ospedale S de Bellis, IRCCS, Castellana Grotte, Bari, Italy
Eur J Gastroenterol Hepatol 18:689-92. 2006
..The patient as a candidate for interferon treatment should therefore be investigated, in addition to thyroid autoimmunity, also for pancreatic autoantibodies before starting therapy...
- Occult hepatitis B virus infection in HIV/hepatitis C virus co-infected patients
Paolo Fabris
AIDS 17:1581-2. 2003
- Three times weekly versus daily dose alpha-interferon treatment in patients with acute hepatitis C
Paolo Fabris
Am J Gastroenterol 97:492-3. 2002
- Clinical pharmacokinetics of nelfinavir and its metabolite M8 in human immunodeficiency virus (HIV)-positive and HIV-hepatitis C virus-coinfected subjects
Mario Regazzi
Clinical Pharmacokinetic Unit, Department of Pharmacology, IRCCS Policlinico San Matteo, Piazzale Golgi 1, 27100 Pavia, Italy
Antimicrob Agents Chemother 49:643-9. 2005
..Therefore, there may be a role for therapeutic drug monitoring in individualizing the NFV dosage in HIV-HCV-coinfected patients...
- Lack of higher frequency of the chemokine receptor 5-delta32/delta32 genotype in hepatitis C
Anna Maria Tommasi
Department of Surgical and Gastroenterological Sciences, University of Padova, Italy
J Clin Gastroenterol 40:440-3. 2006
..The aim of the present study was to verify whether this mutation occurs in an Italian population with hepatitis C and whether it is an adverse host factor indicative of severity of liver disease and response to antiviral therapy...
- Waterborne infections in the era of bioterrorism
Andrea Tramarin
Lancet 360:1699. 2002
- Acute hepatitis C: epidemiology, pathogenesis and therapy
Paolo Fabris
Curr Pharm Des 14:1644-5. 2008
